Jiuliang Zhao

4.1k total citations
231 papers, 2.3k citations indexed

About

Jiuliang Zhao is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Jiuliang Zhao has authored 231 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Rheumatology, 68 papers in Pulmonary and Respiratory Medicine and 59 papers in Immunology. Recurrent topics in Jiuliang Zhao's work include Systemic Lupus Erythematosus Research (119 papers), Pulmonary Hypertension Research and Treatments (40 papers) and Systemic Sclerosis and Related Diseases (39 papers). Jiuliang Zhao is often cited by papers focused on Systemic Lupus Erythematosus Research (119 papers), Pulmonary Hypertension Research and Treatments (40 papers) and Systemic Sclerosis and Related Diseases (39 papers). Jiuliang Zhao collaborates with scholars based in China, United States and United Kingdom. Jiuliang Zhao's co-authors include Mengtao Li, Xiaofeng Zeng, Xinping Tian, Qian Wang, Jing Li, Dong Xu, Zhuang Tian, Qian Wang, Yan Zhao and Chanyuan Wu and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jiuliang Zhao

206 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiuliang Zhao China 24 1.2k 751 570 465 286 231 2.3k
Micki Klearman United States 17 1.8k 1.5× 1.1k 1.4× 598 1.0× 200 0.4× 261 0.9× 31 2.7k
Koichi Amano Japan 28 1.4k 1.1× 602 0.8× 477 0.8× 370 0.8× 179 0.6× 133 2.2k
Alfonso Corrales Spain 25 1.1k 0.9× 345 0.5× 554 1.0× 204 0.4× 336 1.2× 90 1.9k
É. Liozon France 28 1.1k 0.9× 1.4k 1.9× 243 0.4× 272 0.6× 235 0.8× 127 2.3k
Yan Zhao China 29 1.5k 1.2× 319 0.4× 618 1.1× 250 0.5× 273 1.0× 116 2.5k
W. Joseph McCune United States 23 1.4k 1.2× 988 1.3× 796 1.4× 244 0.5× 183 0.6× 41 2.5k
Silvia Laura Bosello Italy 27 820 0.7× 585 0.8× 554 1.0× 1.0k 2.2× 249 0.9× 97 2.3k
Hasan Yazıcı Türkiye 19 1.8k 1.5× 2.1k 2.8× 451 0.8× 244 0.5× 455 1.6× 57 3.4k
Matthew D. Morgan United Kingdom 21 952 0.8× 2.0k 2.7× 522 0.9× 185 0.4× 320 1.1× 41 2.8k
José María Pego‐Reigosa Spain 22 959 0.8× 333 0.4× 503 0.9× 319 0.7× 138 0.5× 82 1.6k

Countries citing papers authored by Jiuliang Zhao

Since Specialization
Citations

This map shows the geographic impact of Jiuliang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiuliang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiuliang Zhao more than expected).

Fields of papers citing papers by Jiuliang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiuliang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiuliang Zhao. The network helps show where Jiuliang Zhao may publish in the future.

Co-authorship network of co-authors of Jiuliang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiuliang Zhao. A scholar is included among the top collaborators of Jiuliang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiuliang Zhao. Jiuliang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lü, Ke, Chanyuan Wu, Jinxi Wang, et al.. (2025). Prevalence and Incidence of Rheumatoid Arthritis in Urban China: A National Population‐Based Study. International Journal of Rheumatic Diseases. 28(5). e70184–e70184. 2 indexed citations
3.
4.
Zhang, Xueyang, Lingshan Liu, Xinwang Duan, et al.. (2025). The conditions that patients with systemic lupus erythematosus should fulfill before pregnancy to optimize outcomes: a large-scale multicenter cohort study from China. Arthritis Research & Therapy. 27(1). 31–31. 1 indexed citations
5.
Yang, Xinzhuang, Yu Chen, Xiuling Zhang, et al.. (2025). The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis. Annals of the Rheumatic Diseases. 84(7). 1221–1230.
6.
Lu, Rui-Jing, Rui Yu, Rong Huang, et al.. (2025). Comparative evaluation of three anti-dsDNA antibody detection methods in systemic lupus erythematosus: insights from a large monocentric cohort. Frontiers in Immunology. 16. 1529484–1529484.
7.
Sun, Xin, Jiuliang Zhao, Ting Zhang, et al.. (2024). Interstitial lung diseases associated with ANCA positivity: A different disease spectrum from interstitial pneumonia with autoimmune features. Respiratory Medicine and Research. 86. 101111–101111. 4 indexed citations
8.
Qian, Junyan, Yangzhong Zhou, Shuang Zhou, et al.. (2024). Case report: Pulmonary artery hypertension secondary to SAPHO syndrome. International Journal of Rheumatic Diseases. 27(5). e15140–e15140. 1 indexed citations
9.
Zhao, Peng, Shuang Zhou, Chanyuan Wu, et al.. (2024). Global trends in research of melanoma differentiation-associated gene 5: a bibliometric analysis from 2002 to 2022. Clinical Rheumatology. 43(3). 1111–1126. 1 indexed citations
11.
Zhou, Shuang, Qiao Lin, Jiuliang Zhao, et al.. (2023). Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products. Frontiers in Endocrinology. 14. 1126661–1126661. 6 indexed citations
12.
Fan, Siyuan, Jiuliang Zhao, Bo Hou, et al.. (2023). Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis. Frontiers in Immunology. 14. 1065650–1065650. 12 indexed citations
13.
Li, Siting, Qian Wang, Xinping Tian, et al.. (2023). Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients. Frontiers in Immunology. 14. 1107510–1107510.
14.
Yang, Fan, Huilan Liu, Yanhong Wang, et al.. (2023). Chinese Registry of Psoriatic Arthritis (CREPAR): I. Clinical characteristics of Chinese patients with psoriatic arthritis. International Journal of Rheumatic Diseases. 26(9). 1737–1744. 4 indexed citations
15.
Jiang, Nan, Can Huang, Shuang Zhou, et al.. (2023). Mortality and prognostic factors in connective tissue disease‐associated pulmonary arterial hypertension patients complicated with right heart failure. International Journal of Rheumatic Diseases. 26(5). 862–869. 7 indexed citations
16.
Jiang, Nan, Shangyi Jin, Yú Chen, et al.. (2023). Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis. Frontiers in Immunology. 14. 1232244–1232244. 6 indexed citations
17.
Qian, Junyan, Xinzhuang Yang, Jiuliang Zhao, et al.. (2023). Association Study Identified HLA‐DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus‐Associated Pulmonary Arterial Hypertension. Arthritis & Rheumatology. 75(12). 2207–2215. 8 indexed citations
18.
Huang, Can, Jiuliang Zhao, Xinping Tian, et al.. (2022). RheumCloud App: A novel mobile application for the management of rheumatic diseases patients in China. PubMed. 3(4). 184–189. 8 indexed citations
19.
Qian, Junyan, Shangzhu Zhang, Dong Xu, et al.. (2022). Immunosuppressive therapy in patients with connective tissue disease‐associated pulmonary arterial hypertension: A systematic review. International Journal of Rheumatic Diseases. 25(9). 982–990. 11 indexed citations
20.
You, Hanxiao, Linyi Peng, Jiuliang Zhao, et al.. (2020). Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis. Journal of Immunology Research. 2020(1). 2156762–2156762. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026